Zhou, Liang <br/><br/>
Downregulation of the Notch signaling pathway inhibits hepatocellular             carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and             vascular endothelial growth factor.  [electronic resource] 

 -  Oncology reports  Sep 2012 
 - 874-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2012.1880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Antineoplastic Agents--pharmacology<br/>Calcium-Calmodulin-Dependent Protein Kinases--antagonists & inhibitors<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Movement<br/>Cell Proliferation<br/>Cell Survival--drug effects<br/>Dipeptides--pharmacology<br/>Down-Regulation<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Flavonoids--pharmacology<br/>Gene Expression--drug effects<br/>Hep G2 Cells--drug effects<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Matrix Metalloproteinase 2--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Neoplasm Invasiveness<br/>Receptors, Notch--genetics<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor A--genetics